Buy or sell Laronde stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.
About Laronde Stock
Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery. Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company is rapidly scaling to support the parallel development of multiple programs across many disease areas.
Co-founder and Chairman of the Board
Co-founder & Board of Directors
Board of Directors
Chief Operating Officer
Chief Technology Officer
Head of Manufacturing
Chief Scientific Officer
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase